Dry Eye Syndromes: all 1,325 studies
Page 11 of 14. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- Single Center, Prospective, Randomized, Controlled, Non-significant RiskWithdrawnNCT03286166
- IPL and MGX Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to MGDCompletedNCT03265652Not applicable
- Effect of an Oral Supplement Containing Omega-3 and Omega-6 on Dry Eye SymptomsCompletedNCT03265327Not applicable
- The Effect of Ablation Depth on Dry Eye After LASIK Treatment of MyopiaCompletedNCT03228784Not applicable
- Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's SyndromeCompletedNCT03226444Phase 1/2
- Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye DiseaseCompletedNCT03216096Phase 1
- Effects of Two Tear Substitutes in Patients With Dry Eye SyndromeCompletedNCT03211351Not applicable
- Laser Acupuncture for Dry EyeStatus unknownNCT03204903Not applicable
- Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry EyeCompletedNCT03183089Phase 4
- Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland DysfunctionCompletedNCT03162497Phase 4
- Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye SyndromeStatus unknownNCT03162094Phase 1/2
- Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye SyndromeCompletedNCT03161080Not applicable
- LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS PatientsStatus unknownNCT03140111Not applicable
- Walnut Shell Glasses Moxibustion for Dry Eye SyndromeStatus unknownNCT03116776Not applicable
- HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)CompletedNCT03108664Phase 3
- Automatic Self Transcending Meditation (ASTM) in Patients With Dry Eye DiseaseStatus unknownNCT03087006Not applicable
- Allogeneic Versus Autologous Serum Eye DropsCompletedNCT03085290Not applicable
- An Open Label Comparing the Short Term Efficacy of LacrisertStatus unknownNCT03079271Phase 4
- Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry EyeCompletedNCT03074344Not applicable
- Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16)CompletedNCT03061578
- Lamelleye vs Comparator for the Treatment of Dry Eye DiseaseCompletedNCT03052140Not applicable
- The Impact of Hypo-osmolar Drops on Contact Lens ComfortCompletedNCT03050125Not applicable
- Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye DiseaseCompletedNCT03048526Not applicable
- Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry EyeCompletedNCT03012698Not applicable
- Effect of Intense Pulse Light (IPL) Treatment on Tear Film OsmolarityStatus unknownNCT02992535Phase 4
- Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye SyndromeStatus unknownNCT02992392Not applicable
- Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02986750Phase 4
- Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02980913Not applicable
- Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland DysfunctionCompletedNCT02958514Not applicable
- The Effect of Tear Supplements on Contact Lens ComfortCompletedNCT02956083Not applicable
- A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry EyeCompletedNCT02951910Phase 4
- Fingerprick Autologous Blood (FAB) in Mebomian Gland Dysfunction (MGD)Status unknownNCT02943382Not applicable
- Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye SyndromeCompletedNCT02917512Phase 2
- Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry EyeCompletedNCT02908282Not applicable
- Interest of Eye Movement Measurements in the Comprehension of Dry Eyes SymptomsCompletedNCT02851654
- Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.Status unknownNCT02849093
- The Effect of Oral Zanthoxylum Schinifolium Seed Oil in Individuals With Dry Eye DiseaseCompletedNCT02802150Not applicable
- Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With PterygiumStatus unknownNCT02782260Phase 2
- Study to Evaluate the Efficacy and Safety of CKD-350Status unknownNCT02777723Phase 3
- Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye SyndromeStatus unknownNCT02774707
- Effect of Nursing Care on Prevention of Dry EyeStatus unknownNCT02767258Not applicable
- In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry EyeCompletedNCT02764814Not applicable
- Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating DropsCompletedNCT02758327Phase 4
- Comparison of Autologous Serum Versus Preservative Free Artificial TearCompletedNCT02752763Phase 4
- Phase 1 Study for Safety and Tolerability of HL036CompletedNCT02717208Phase 1
- Exploring Immune Cell Signatures in Autoimmunity and Dry Eye SyndromeCompletedNCT02715323
- Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) PatientsCompletedNCT02712762
- Effects of a Moisturizing Product on Dry Eye and SkinCompletedNCT02683382Not applicable
- A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye DiseaseCompletedNCT02665234Phase 3
- Evaluation of Factors Affecting the Tear-film Lipid Layer ThicknessCompletedNCT02645045
- A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT02634853Phase 3
- Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGDCompletedNCT02621593Not applicable
- Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye SyndromeTerminatedNCT02617095Not applicable
- Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1CompletedNCT02597803Phase 2/3
- 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic PatientsStatus unknownNCT02595606Phase 4
- Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02585648Not applicable
- Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02585453Phase 4
- Optical Coherence Tomography of Tear Film Dynamics In-VivoCompletedNCT02554084Not applicable
- Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye PatientsStatus unknownNCT02533154Phase 4
- A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens PatientsCompletedNCT02522312
- A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503189Phase 3
- An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeTerminatedNCT02503176Phase 3
- A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503163Phase 3
- Lipid Layer Thickness Pre and Post Lid Scrubs With CliradexCompletedNCT02493244Not applicable
- Efficacy and Safety of HE10 for Dry Eye SyndromeCompletedNCT02492412Phase 3
- Evaluation of Meibomian Gland Dysfunction in Chinese Old PatientsStatus unknownNCT02481167
- Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye SyndromesCompletedNCT02461719Phase 3
- Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular PainCompletedNCT02455999Phase 2
- Three Dimension Tomography of Eye Structures by White Light Imaging DeviceStatus unknownNCT02424266
- Dry Eye Treatment With Artificial TearsCompletedNCT02420834Not applicable
- Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry EyeCompletedNCT02420730Phase 1
- Tear Osmolarity Clinical Utility in Dry Eye DiseaseCompletedNCT02417116Not applicable
- Study of EBI-005 in Dry Eye Disease (DED)Status unknownNCT02405039Phase 3
- Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry EyeCompletedNCT02403219Phase 1
- The Effect of Eyelid Surgery on Dry Eye - a Prospective StudyCompletedNCT02376556
- Study of ST266 Eye Drops in Treating Dry EyeCompletedNCT02369861Phase 1
- NovaTears® Eye Drops Observational Study NT-002CompletedNCT02356341
- NovaTears® Eye Drops Observational Study NT-003CompletedNCT02356328
- Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry EyeCompletedNCT02326090Phase 2
- Point of Care Testing of Inflammatory Markers in TearsCompletedNCT02315079
- Ocular Surface Dry Eye MicrobiomeStatus unknownNCT02306668
- Ocular Surface MicrobiomeCompletedNCT02298881
- The Influence of PRN Omega-3 Nutritional Supplement on Visual AcuityStatus unknownNCT02260973Phase 2/3
- The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye DiseaseCompletedNCT02260960Phase 2/3
- Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT02242032Phase 1
- Efficacy and Safety of XG-104 for the Treatment of Dry EyeCompletedNCT02235259Phase 2
- Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye DiseaseCompletedNCT02229955Phase 3
- Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry EyeCompletedNCT02219204Not applicable
- Topical Steroid Treatment For Dry EyeStatus unknownNCT02218827Not applicable
- Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus PatientsCompletedNCT02217137
- Dry Eye Evaluation After Transepithelial PRKCompletedNCT02210793Not applicable
- A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.CompletedNCT02205840Phase 2/3
- Ocular Surface Microbiome in Dry Eye PatientsCompletedNCT02161341
- The Role of Cytokines and Mast Cell in the Pathogenesis of SLK, Conjunctivochalasis, and Dry EyeStatus unknownNCT02160327
- Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous BloodStatus unknownNCT02153515Phase 3
- Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's SyndromeCompletedNCT02147509Not applicable
- A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye SyndromeCompletedNCT02139033Phase 4
- Examining the Immunological Process of Autoimmune PatientsWithdrawnNCT02123147
- Civamide Nasal Solution for the Treatment of Dry EyeCompletedNCT02116244Phase 2
- NovaTears® Eye Drops Observational StudyCompletedNCT02111928